PEMETREXED TEVA RTU 25 MGML

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Viambatanisho vya kazi:

PEMETREXED

Inapatikana kutoka:

ABIC MARKETING LTD, ISRAEL

ATC kanuni:

L01BA04

Dawa fomu:

CONCENTRATE FOR SOLUTION FOR INFUSION

Tungo:

PEMETREXED 25 MG / 1 ML

Njia ya uendeshaji:

I.V

Dawa ya aina:

Required

Viwandani na:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Eneo la matibabu:

PEMETREXED

Matibabu dalili:

Pemetrexed Teva RTU in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. Pemetrexed Teva RTU in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva RTU is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Teva RTU is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

Idhini ya tarehe:

2018-01-03